ChemWerth Announces New Board of Directors Member

May 12, 2026 | News

WOODBRIDGE, Conn. – ChemWerth, a leading supplier of generic active pharmaceutical ingredients (APIs), today announced the appointment of Tim Aust, M.D., to its Board of Directors. Dr. Aust succeeds Randy Wingate, who is stepping down after years of dedicated service....

ChemWerth Announces Leadership Change

May 4, 2026 | News

WOODBRIDGE, Conn. – ChemWerth, a leading supplier of generic active pharmaceutical ingredients (APIs), today announced the promotion of Vincent “Vinny” Asaro to President of ChemWerth Inc. Vinny started at ChemWerth nearly 20 years ago and has served the majority of...

SpeakPharma Interview With Pete Werth III

Mar 25, 2025 | News

Our Unmatched Efficiency and Track Record of Faster DMF Filings Give Our Customers a Critical Competitive Advantage Read Here: “Our unmatched efficiency and track record of faster DMF filings give our customers a critical competitive advantage” | Speak Pharma This...

Nitrosamines and Genotoxic Impurities

Feb 11, 2025 | News, White Papers

Please click the below link to view our most recent white paper that details the FDA’s guidance on nitrosamines/genotoxic impurities and how ChemWerth has developed a procedure to prevent our products from containing them. Nitrosamines and Genotoxic...

The ChemWerth Advantage

Feb 11, 2025 | News, White Papers

Please click the below link to view our most recent white paper explaining The ChemWerth Advantage and how we are able to get products to market at an unmmatched pace. The ChemWerth Advantage